0001127602-23-018598.txt : 20230612 0001127602-23-018598.hdr.sgml : 20230612 20230612175219 ACCESSION NUMBER: 0001127602-23-018598 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wright Christopher I CENTRAL INDEX KEY: 0001838503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 231009558 MAIL ADDRESS: STREET 1: C/O CYCLERION THERAPEUTICS, INC. STREET 2: 245 FIRST STREET, 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-06-08 0001520262 Alkermes plc. ALKS 0001838503 Wright Christopher I CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 Ireland 1 0 Ordinary Shares 2023-06-08 4 M 0 373 A 373 D Ordinary Shares 2023-06-08 4 F 0 90 31.54 D 283 D Ordinary Shares 2023-06-08 4 M 0 3236 A 3519 D Ordinary Shares 2023-06-08 4 F 0 777 31.54 D 2742 D Restricted Stock Unit Award 2023-06-08 4 M 0 373 D Ordinary Shares 373 0 D Restricted Stock Unit Award 2023-06-08 4 M 0 3236 D Ordinary Shares 3236 6473 D Each restricted stock unit represents a contingent right to receive one ordinary share. This award is fully vested in accordance with its terms. Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 6/8/2023. /s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright 2023-06-12